Gilead files COVID-19 drug remdesivir with FDAGilead has filed its COVID-19 drug remdesivir with the FDA, to treat patients with severe disease, under the Share XGilead files COVID-19 drug remdesivir with FDAhttps://pharmaphorum.com/news/gilead-files-covid-19-drug-remdesivir-with-fda/
Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’Swiss medical data specialist Sophia Genetics has launched a platform that will sift through data generated at more Share XSophia Genetics launches AI tool to find COVID-19 ‘unknowns’https://pharmaphorum.com/news/sophia-genetics-launches-ai-tool-to-find-covid-19-unknowns/
Pfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivirPfizer has signed a multi-year agreement with Gilead to manufacture and supply the COVID-19 antiviral remdesivir, which is Share XPfizer signs deal with Gilead to manufacture COVID-19 antiviral remdesivirhttps://pharmaphorum.com/news/pfizer-signs-deal-with-gilead-to-manufacture-covid-19-antiviral-remdesivir/
Coronavirus pharma news roundup – 07/08/20Pharma’s reputation has soared due to the COVID-19 pandemic – but coronavirus is starting to bite companies’ sales. Share XCoronavirus pharma news roundup – 07/08/20https://pharmaphorum.com/r-d/views-analysis-r-d/coronavirus-pharma-news-roundup-07-08-20/
Novavax says COVID-19 vaccine could be approved by year-endNovavax’s COVID-19 vaccine produced higher levels of neutralising antibodies than produced by recovered patients in an early trial, Share XNovavax says COVID-19 vaccine could be approved by year-endhttps://pharmaphorum.com/news/novavax-says-covid-19-vaccine-could-be-approved-by-year-end/
Government warned over test and trace as UK schools prep to reopenThe current level of test and trace in the UK is inadequate to prevent a sharp increase in Share XGovernment warned over test and trace as UK schools prep to reopenhttps://pharmaphorum.com/news/government-warned-over-test-and-trace-as-uk-schools-prep-to-reopen/
Mental health platform helps students facing exam results during pandemicThe UK digital mental health support platform Kooth has joined with five of the UK’s well known Instagram Share XMental health platform helps students facing exam results during pandemichttps://pharmaphorum.com/news/digital-mental-health-platform-supports-students-during-pandemic-exam-results-season/
Bayer slides on €9.5bn loss caused by litigation, COVID-19 impactBayer counted the cost of its expensive Roundup weedkiller settlement in the second quarter with a €9.5 billion Share XBayer slides on €9.5bn loss caused by litigation, COVID-19 impacthttps://pharmaphorum.com/news/bayer-slides-on-e9-5bn-loss-caused-by-litigation-covid-19-impact/
Lilly’s antibody for COVID-19 protection starts nursing home trialWhile the world waits an effective coronavirus vaccine, Eli Lilly has started late-stage human testing an antibody drug Share XLilly’s antibody for COVID-19 protection starts nursing home trialhttps://pharmaphorum.com/news/lillys-antibody-for-covid-19-protection-starts-nursing-home-trial/
